Both in Pharmaceuticals
Aurinia Pharmaceuticals vs Immunome
Over the past year AUPH returned +25.7% and IMNM returned +19.5%; their daily moves had a correlation of 0.19.
AUPH +25.7% IMNM +19.5%Growth of $1, one year, split-adjusted
| Metric | AUPH | IMNM |
|---|---|---|
| Price | $16.56 | $20.31 |
| Market cap | $2.22B | $2.40B |
| Today | +2.60% | +3.68% |
| 1 month | +5.3% | −4.1% |
| 6 months | +3.2% | −12.1% |
| Year to date | +3.8% | −5.4% |
| 1 year | +25.7% | +26.4% |
| Revenue growth (YoY) | +13.9% | −100.0% |
| Gross margin | 90.1% | — |
| Net margin | 37.9% | — |
| P/E (TTM) | 7.1× | — |
| Price / sales | 6.9× | — |
| Net cash | $431.7M | $520.0M |
| Dividend yield | — | — |
| Volatility (60d) | 30.3% | 57.8% |
| Short % of float | 7.3% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).